Skip to main content

Table 1 Selection of MARV epitopes

From: Discovery of common marburgvirus protective epitopes in a BALB/c mouse model

Peptide Poola

+ Peptide from Poolb

15-mer Sequence

% CD8 IFNγc

9-mer Peptide Motif Resultsd

% CD8 IFNγ e

GP1-13

GP2

FLISLILIQGTKNLP

2.85

ILIQGTKNL

2.83

GP1-14

GP3

ILIQGTKNLPILEIA

5.09

QGTKNLPIL

3.46

GP2-17

GP19

TCYNISVTDPSGKSL

2.34

VTDPSGKSL

1.68

GP2-19

GP21

SGKSLLLDPPTNIRD

2.6

LLLDPPTNI

1.72

GP7-17

GP84

SPPPTPSSTAQHLVY

3.11

TPSSTAQHL

2.93

GP11-13

GP132

GILLLLSIAVLIALS

8.36

LLLSIAVLI

8.94

GP11-14

GP133

LSIAVLIALSCICRI

2.96

LSIAVLIAL

1.18

GP11-15

GP134

LIALSCICRIFTKYI

2.73

IALSCICRI

4.12

NP1-20

NP144

AINSGIDLGDLLEGG

2.88

NSGIDLGDL

4.13

NP2-13

NP150

KFNTSPVAKYLRDAG

2.53

NTSPVAKYL

4.71

NP2-20

NP157

EPHYSPLILALKTLE

3.48

HYSPLILAL

2.79

VP6-12

VP44

QHKNPNNGPLLAISG

3.17

KNPNNGPLL

2.38

  1. *Tested in adoptive transfer studies
  2. aPools of peptides were each number represents a new 15-mer peptide
  3. bSelected 15-mer peptides capable of restimulating splenocytes of MARV-infected mice
  4. cMean IFNγ levels from two experiments minus mean background
  5. d9 mers derived from HLA binding predictions